Literature DB >> 9175905

Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba.

J Klein1, S S Chatterjee, K Löffelholz.   

Abstract

A marked increase of choline release from rat hippocampal slices was observed when the slices were superfused with oxygen-free buffer, indicating hypoxia-induced hydrolysis of choline-containing phospholipids. This increase of choline release was suppressed by bilobalide, an ingredient of Ginkgo biloba, but not by a mixture of ginkgolides. The EC50 value for bilobalide was 0.38 microM. In ex vivo experiments, bilobalide also inhibited hypoxia-induced choline release when given p.o. in doses of 2-20 mg/kg 1 h prior to slice preparation. The half-maximum effect was observed with 6 mg/kg bilobalide. A similar effect was noted after p.o. administration of 200 mg/kg EGb 761, a ginkgo extract containing approximately 3% of bilobalide. We conclude that ginkgo extracts can suppress hypoxia-induced membrane breakdown in the brain, and that bilobalide is the active constituent for this effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175905     DOI: 10.1016/s0006-8993(97)00239-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood.

Authors:  Albert Attia; Stephen R Rapp; L Doug Case; Ralph D'Agostino; Glenn Lesser; Michelle Naughton; Kevin McMullen; Robin Rosdhal; Edward G Shaw
Journal:  J Neurooncol       Date:  2012-06-15       Impact factor: 4.130

2.  Neuroprotective effects of bilobalide are accompanied by a reduction of ischemia-induced glutamate release in vivo.

Authors:  Dorothee Lang; Cornelia Kiewert; Alexander Mdzinarishvili; Tina Maria Schwarzkopf; Rachita Sumbria; Joachim Hartmann; Jochen Klein
Journal:  Brain Res       Date:  2011-10-06       Impact factor: 3.252

3.  A Bilobalide-Producing Endophytic Fungus, Pestalotiopsis uvicola from Medicinal Plant Ginkgo biloba.

Authors:  Yi-Xin Qian; Ji-Chuan Kang; Yi-Kai Luo; Jun-Jie Zhao; Jun He; Kun Geng
Journal:  Curr Microbiol       Date:  2016-05-07       Impact factor: 2.188

Review 4.  Combination therapy in Alzheimer's disease: a review of current evidence.

Authors:  Beate Schmitt; Tanja Bernhardt; Hans-Juergen Moeller; Isabella Heuser; Lutz Frölich
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Role of GABAergic antagonism in the neuroprotective effects of bilobalide.

Authors:  Cornelia Kiewert; Vikas Kumar; Oksana Hildmann; Misty Rueda; Joachim Hartmann; Runa S Naik; Jochen Klein
Journal:  Brain Res       Date:  2006-11-28       Impact factor: 3.252

Review 6.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 7.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

8.  Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine.

Authors:  Roger L Papke; William R Kem; Ferenc Soti; Gretchen Y López-Hernández; Nicole A Horenstein
Journal:  J Pharmacol Exp Ther       Date:  2009-02-17       Impact factor: 4.030

9.  Effects of bilobalide on hypoxia/hypoglycemia-stimulated glutamate efflux from rat cortical brain slices.

Authors:  Lisa Johns; Alan J Sinclair; John A Davies
Journal:  Neurochem Res       Date:  2002-05       Impact factor: 3.996

10.  Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegans.

Authors:  Marishka K Brown; Yuan Luo
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.